Transforming Cardiovascular Disease Prevention in Women: Time for the Pygmalion Construct to End

Publisher： Karger

E-ISSN： 1421-9751|130|1|62-68

ISSN： 0008-6312

Source： Cardiology, Vol.130, Iss.1, 2014-12, pp. : 62-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin and cardiovascular disease prevention in women: new findings from the Women’s Health Study

By Bassuk Shari S   Ridker Paul M   Manson JoAnn E   Buring Julie E  

Women's Health, Vol. 1, Iss. 1, 2005-07 ,pp. : 9-10

Future Medicine

Access to resources Recommend Favorite

Interventions for cardiovascular disease in women

By Grinfeld Liliana   Rolandi Florencia  

Women's Health, Vol. 5, Iss. 4, 2009-07 ,pp. : 437-446

Future Medicine

Access to resources Recommend Favorite

Aspirin for prevention of cancer and cardiovascular disease

By Rose Peter W   Watson Eila K   Jenkins Lucy SC  

British Journal of General Practice, Vol. 61, Iss. 587, 2011-06 ,pp. : 412-415

Royal College of General Practitioners

Access to resources Recommend Favorite

Cardiovascular disease prevention and markers of hyperlipoproteinemia

By Gaddi Antonio V   Malvi Cristina  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 255-258

Future Medicine

Access to resources Recommend Favorite

Primary prevention of cardiovascular disease with HRT

By Maclaran Kate   Stevenson John C  

Women's Health, Vol. 8, Iss. 1, 2012-01 ,pp. : 63-74

Future Medicine

Access to resources Recommend Favorite